日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

NEXUS: a phase I dose escalation study of selinexor plus nivolumab and ipilimumab in Asian patients with advanced/metastatic solid malignancies

NEXUS：一项针对亚洲晚期/转移性实体恶性肿瘤患者的selinexor联合nivolumab和ipilimumab的I期剂量递增研究

期刊:Therapeutic Advances in Medical Oncology
影响因子:4.2
doi:10.1177/17588359251339930
R Choo, Joan; Jeraj, Santhiay Nathan; Sundar, Raghav; Yong, Wei Peng; Lee, Matilda; Huang, Yiqing; Asokumaran, Yugarajah; Chan, Gloria H J; Ngoi, Natalie Y L; Wong, Andrea L A; Soo, Ross A; Chee, Cheng Ean; Lim, Joline S J; Goh, Boon Cher; Lee, Soo Chin; Tan, David S P
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Molecular profiling of metastatic breast cancer and target-based therapeutic matching in an Asian tertiary phase I oncology unit

亚洲一家三级I期肿瘤专科中心对转移性乳腺癌进行分子谱分析和靶向治疗匹配

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2024.1342346
Walsh, Robert John; Ong, Rebecca; Cheo, Seng Wee; Low, Peter Q J; Jayagopal, Aishwarya; Lee, Matilda; Ngoi, Natalie; Ow, Samuel G; Wong, Andrea L A; Lim, Siew Eng; Lim, Yi Wan; Heong, Valerie; Sundar, Raghav; Soo, Ross A; Chee, Cheng Ean; Yong, Wei Peng; Goh, Boon Cher; Lee, Soo Chin; Tan, David S P; Lim, Joline S J
肿瘤
肿瘤免疫
乳腺癌
发表日期：2024
文献求助 收藏

Phase Ib Dose-Finding Study of Varlitinib Combined with Weekly Paclitaxel With or Without Carboplatin ± Trastuzumab in Advanced Solid Tumors

Varlitinib联合每周一次紫杉醇，加或不加卡铂±曲妥珠单抗治疗晚期实体瘤的Ib期剂量探索研究

期刊:Targeted Oncology
影响因子:4
doi:10.1007/s11523-022-00867-0
Lee, Matilda Xinwei; Wong, Andrea L A; Ow, Samuel; Sundar, Raghav; Tan, David S P; Soo, Ross A; Chee, Cheng Ean; Lim, Joline S J; Yong, Wei Peng; Lim, Siew Eng; Goh, Boon Cher; Wang, Lingzhi; Lee, Soo Chin
发表日期：2022
文献求助 收藏

Targeting Metabolism in Cancer Cells and the Tumour Microenvironment for Cancer Therapy

靶向癌细胞代谢和肿瘤微环境的癌症治疗

期刊:Molecules
影响因子:4.6
doi:10.3390/molecules25204831
Li, Jiaqi; Eu, Jie Qing; Kong, Li Ren; Wang, Lingzhi; Lim, Yaw Chyn; Goh, Boon Cher; Wong, Andrea L A
肿瘤
肿瘤免疫
代谢
细胞生物学
肿瘤微环境
发表日期：2020
文献求助 收藏

Photodynamic Inactivation of Herpes Simplex Viruses

光动力灭活单纯疱疹病毒

期刊:Viruses-Basel
影响因子:3.8
doi:10.3390/v10100532
Andrea L-A Monjo, Eric S Pringle, Mackenzie Thornbury, Brett A Duguay, Susan M A Monro, Marc Hetu, Danika Knight, Colin G Cameron, Sherri A McFarland, Craig McCormick
免疫
微生物学
疱疹
WB
发表日期：2018
文献求助 收藏

Phase Ib/II randomized, open-label study of doxorubicin and cyclophosphamide with or without low-dose, short-course sunitinib in the pre-operative treatment of breast cancer

一项 Ib/II 期随机、开放标签研究，评估多柔比星和环磷酰胺联合或不联合低剂量、短期舒尼替尼用于乳腺癌术前治疗的疗效。

期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.11596
Wong, Andrea L A; Sundar, Raghav; Wang, Ting-Ting; Ng, Thian-C; Zhang, Bo; Tan, Sing-Huang; Soh, Thomas I P; Pang, Angela S L; Tan, Chee-Seng; Ow, Samuel G W; Wang, Lingzhi; Mogro, Jannet; Ho, Jingshan; Jeyasekharan, Anand D; Huang, Yiqing; Thng, Choon-Hua; Chan, Ching-Wan; Hartman, Mikael; Iau, Philip; Buhari, Shaik A; Goh, Boon-Cher; Lee, Soo-Chin
肿瘤
肿瘤免疫
乳腺癌
发表日期：2016
文献求助 收藏

Correlation of aldo-ketoreductase (AKR) 1C3 genetic variant with doxorubicin pharmacodynamics in Asian breast cancer patients

亚洲乳腺癌患者中醛酮还原酶 (AKR) 1C3 基因变异与阿霉素药效学的相关性

期刊:British Journal of Clinical Pharmacology
影响因子:3
doi:10.1111/bcp.12021
Voon, Pei Jye; Yap, Hui Ling; Ma, Cho-Yee-Thu; Lu, Fan; Wong, Andrea L A; Sapari, Nur Sabrina; Soong, Richie; Soh, Thomas I P; Goh, Boon-Cher; Lee, How-Sung; Lee, Soo-Chin
肿瘤
肿瘤免疫
乳腺癌
发表日期：2013
文献求助 收藏

Mechanisms of Resistance to Trastuzumab and Novel Therapeutic Strategies in HER2-Positive Breast Cancer

HER2阳性乳腺癌对曲妥珠单抗的耐药机制及新型治疗策略

期刊:International Journal of Breast Cancer
影响因子:3
doi:10.1155/2012/415170
Wong, Andrea L A; Lee, Soo-Chin
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2012
文献求助 收藏